≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

Vasculitis limited to skin, not elsewhere classified

DOID Endpoint Browser

L12_VASCULITISSKIN

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — L95
  • Cause of death: ICD-10 — L95

2 out of 7 registries used, show all original rules.

914

4. Check minimum number of events

None

914

5. Include endpoints

914

6. Filter based on genotype QC (FinnGen only)

914

Control definitions (FinnGen only)

Control exclude
L12_OTHERSKINSUBCUTIS

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
L80-L99
Name in latin
Vasculitis solummodo cutanea non alibi classificata

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 914 531 383
Unadjusted period prevalence (%) 0.18 0.18 0.17
Median age at first event (years) 61.47 60.84 62.33

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
830
Matched controls
8298
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
L95.8
ICD-10 Finland
Other vasculitis limited to skin
+∞
323.0
322
*
L95.9
ICD-10 Finland
Vasculitis limited to skin, unspecified
14451.0
323.0
556
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
22.2
265.6
424
372
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
80.0
158.9
177
28
H02AB06
ATC
prednisolone; systemic
8.0
150.3
669
2828
D69.0
ICD-10 Finland
Allergic purpura
163.7
132.7
137
10
L95.0
ICD-10 Finland
Livedoid vasculitis
+∞
119.7
112
*
S97
ICPC
Chronic ulcer skin
14.6
104.6
185
160
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
18.4
97.8
156
103
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
80.7
95.0
106
15
L30.9
ICD-10 Finland
Dermatitis, unspecified
4.8
70.7
284
810
J04BA02
ATC
dapsone; oral
84.9
69.4
77
10
I83.0
ICD-10 Finland
Varicose veins of lower extremities with ulcer
22.8
69.0
101
50
L04AX01
ATC
azathioprine; systemic
11.0
66.5
133
142
A46
ICD-10 Finland
Erysipelas
5.0
66.0
248
652
D07AC01
ATC
betamethasone; topical
3.7
65.8
428
1865
TQW80
NOMESCO Finland
Local dermatologic skincare
17.8
65.7
105
67
SPAT1148
SPAT
Treatment of chronic ulcer or burn
5.0
64.0
240
627
J01FF01
ATC
clindamycin; systemic
3.7
60.8
353
1376
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
3.4
58.1
419
1919
E0000UV
ATC
NA
3.1
50.0
436
2205
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
20.7
49.3
74
39
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
6.6
48.5
133
232
D07AD01
ATC
clobetasol; topical
4.0
48.0
223
694
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.0
48.0
473
2571
C03CA01
ATC
furosemide; systemic
3.1
47.2
354
1596
QDG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of lower limb
46.1
39.5
48
11
N02AX02
ATC
tramadol; systemic, rectal
2.6
38.4
434
2437
ZZA00
NOMESCO Finland
Split skin graft
10.9
38.3
75
75
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
12.4
37.7
69
60
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.7
37.1
183
585
D07AB08
ATC
desonide; topical
4.2
37.1
157
439
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
4.3
35.6
145
390
J01DB01
ATC
cefalexin; oral
3.3
35.4
724
5607
A02BC02
ATC
pantoprazole; systemic
2.5
33.0
594
4139
P01BA02
ATC
hydroxychloroquine; oral
4.4
32.6
127
326
S18
ICPC
Laceration/cut
2.4
31.7
417
2449
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
4.3
31.5
127
336
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.5
29.4
151
492
L50.9
ICD-10 Finland
Urticaria, unspecified
7.6
29.2
70
99
J01MA02
ATC
ciprofloxacin; systemic
2.3
29.0
385
2238
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.5
28.2
297
1526
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
3.3
27.7
156
542
XQ848
NOMESCO Finland
Dermatological photography
9.9
27.6
56
60
J01MA12
ATC
levofloxacin; systemic
2.8
27.1
201
844
E000001
ATC
NA
2.7
26.5
223
1006
L98.9
ICD-10 Finland
Disorder of skin and subcutaneous tissue, unspecified
53.5
26.4
31
6
H02AB07
ATC
prednisone; oral
3.0
26.3
178
702
L04AA06
ATC
mycophenolic acid; systemic
12.1
26.2
48
42
M31.9
ICD-10 Finland
Necrotizing vasculopathy, unspecified
62.1
26.1
30
5
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
3.4
26.0
139
465
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
4.3
25.8
102
263
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
3.2
25.2
144
504
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
5.4
25.0
78
157
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.5
25.0
245
1197
C03DA01
ATC
spironolactone; oral
3.4
24.8
135
454
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
5.2
24.3
78
162
M04AA01
ATC
allopurinol; systemic
3.0
24.0
155
589
N02AA05
ATC
oxycodone; systemic
2.8
23.7
170
692
D07AC13
ATC
mometasone; topical
2.3
23.5
285
1542
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
3.6
23.5
112
341
R60.0
ICD-10 Finland
Localized oedema
3.1
23.0
141
515
M30.0
ICD-10 Finland
Polyarteritis nodosa
123.4
22.7
24
*
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.5
22.6
113
357
TQW11
NOMESCO Finland
Vacuum treatment of wound
12.7
22.5
40
33
I83.2
ICD-10 Finland
Varicose veins of lower extremities with both ulcer and inflammation
27.2
21.5
29
11
NHQ40
NOMESCO Finland
Amputation of toe
16.1
21.2
34
22
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.8
20.9
151
612
I50.9
ICD-10 Finland
Heart failure, unspecified
2.7
20.6
159
671
S76
ICPC
Skin infection other
4.6
20.6
73
169
D69.2
ICD-10 Finland
Other nonthrombocytopenic purpura
42.8
20.5
25
6
L89
ICD-10 Finland
Decubitus ulcer and pressure area
49.3
20.2
24
5
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
3.8
20.1
89
254
L04AA01
ATC
[U] ciclosporin; systemic
11.0
20.1
38
36
N08.2*D69.0
ICD-10 Finland
Glomerular disorders in Henoch(-Schönlein) purpura
59.0
20.0
23
*
ZXE00
NOMESCO Finland
One hour or less
2.0
19.7
367
2347
I83.1
ICD-10 Finland
Varicose veins of lower extremities with inflammation
7.0
19.7
49
74
A02BC01
ATC
omeprazole; systemic
2.1
19.4
266
1499
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
2.7
19.4
141
575
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
3.6
19.1
89
265
D09AB01
ATC
zinc bandage without supplements; topical
8.0
19.0
43
56
L95.1
ICD-10 Finland
Erythema elevatum diutinum
+∞
18.8
18
*
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
4.4
18.7
69
166
H02AB09
ATC
hydrocortisone; systemic
7.6
18.7
44
61
L81.7
ICD-10 Finland
Pigmented purpuric dermatosis
194.2
18.6
19
*
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
3.3
18.1
95
310
SPAT1149
SPAT
Suture or treatment of traumatic wound
2.6
18.1
144
615
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
3.4
18.0
93
300
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.4
18.0
169
790
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.5
17.9
161
736
L52
ICD-10 Finland
Erythema nodosum
23.4
17.8
25
11
B01AA03
ATC
warfarin; systemic
2.2
17.7
209
1092
R06.0
ICD-10 Finland
Dyspnoea
2.1
17.7
246
1383
N08.2*D89.80
ICD-10 Finland
Immunoglobulin A (IgA) nephropathy
16.0
17.6
28
18
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
3.4
17.4
88
279
R50.9
ICD-10 Finland
Fever, unspecified
2.5
17.4
146
643
C07AB07
ATC
bisoprolol; oral
1.9
17.4
420
2913
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.4
17.3
165
777
S29
ICPC
Skin symptom/complaint other
2.4
17.3
172
828
I50.0
ICD-10 Finland
Congestive heart failure
3.3
17.3
92
304
L50.8
ICD-10 Finland
Other urticaria
8.0
17.3
39
51
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.0
17.2
104
376
SPAT1151
SPAT
Treatment of major wounds
12.4
16.9
30
25
L88
ICD-10 Finland
Pyoderma gangrenosum
+∞
16.7
16
*
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
5.9
16.7
47
84
R06AE09
ATC
levocetirizine; oral
2.6
16.6
131
557
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
4.6
16.6
58
133
M31.8
ICD-10 Finland
Other specified necrotizing vasculopathies
173.3
16.6
17
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.2
16.5
192
994
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
9.0
16.3
34
39
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.7
16.3
72
205
A41.9
ICD-10 Finland
Sepsis, unspecified
4.9
16.0
53
115
J01CF05
ATC
flucloxacillin; systemic
4.5
15.9
57
134
D02AX
ATC
Other emollients and protectives
5.2
15.9
49
98
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
10.7
15.8
30
29
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
3.4
15.6
79
251
ZXE10
NOMESCO Finland
More than one and less than three hours
1.9
15.4
323
2105
E11.5
ICD-10 Finland
Type 2 diabetes mellitus, with peripheral circulatory complications
11.5
15.3
28
25
D07AB02
ATC
hydrocortisone butyrate; topical
2.0
15.3
252
1501
E000003
ATC
NA
4.0
15.3
62
164
205
Kela drug reimbursment
Chronic hypertension
2.0
15.2
258
1554
ZXD05
NOMESCO Finland
Urgent procedure
1.9
15.2
278
1722
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
2.0
15.1
220
1249
SPAT1211
SPAT
Application of soft bandage
2.7
15.1
106
420
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
4.0
15.0
60
157
M13.9
ICD-10 Finland
Arthritis, unspecified
3.1
15.0
86
300
N03AX16
ATC
pregabalin; oral
2.0
14.8
219
1247
PF1AT
NOMESCO Finland
Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)
18.8
14.7
22
12
L04AD01
ATC
ciclosporin; systemic
7.3
14.7
35
50
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.4
14.7
73
229
N17.9
ICD-10 Finland
Acute renal failure, unspecified
4.5
14.7
52
121
I48
ICD-10 Finland
Atrial fibrillation and flutter
2.0
14.6
216
1231
N03AX12
ATC
gabapentin; oral
2.3
14.5
152
745
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
6.3
14.4
38
63
M79.6
ICD-10 Finland
Pain in limb
1.8
14.4
315
2068
PD4CG
NOMESCO Finland
Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet
11.6
14.4
26
23
WX213
NOMESCO Finland
Lower leg blockade
17.3
14.4
22
13
L08.9
ICD-10 Finland
Local infection of skin and subcutaneous tissue, unspecified
5.0
14.3
46
97
UJF32
NOMESCO Finland
Coloscopy
1.9
14.1
237
1416
Z3231
NOMESCO Finland
Registered nurse
1.9
14.1
246
1490
B01AB05
ATC
enoxaparin; parenteral
1.9
14.1
274
1726
D64.9
ICD-10 Finland
Anaemia, unspecified
2.6
13.9
108
453
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
3.1
13.8
77
262
M05BA04
ATC
alendronic acid; oral
2.6
13.7
102
418
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.3
13.2
68
219
I10
ICD-10 Finland
Essential (primary) hypertension
1.7
13.1
488
3746
KA1AE
NOMESCO Finland
Kidney ultrasound examination
5.7
13.1
37
67
QD9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in lower extremities, unspecified
28.9
13.0
17
6
D69.9
ICD-10 Finland
Haemorrhagic condition, unspecified
19.4
12.9
19
10
N18.8
ICD-10 Finland
Other chronic renal failure
4.9
12.7
41
87
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
2.2
12.6
135
667
WZC30
NOMESCO Finland
Teaching
2.2
12.6
135
667
M30.8
ICD-10 Finland
Other conditions related to polyarteritis nodosa
+∞
12.5
12
*
D03BA02
ATC
collagenase; topical
24.7
12.5
17
7
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
7.0
12.5
30
44
R53
ICD-10 Finland
Malaise and fatigue
2.0
12.3
188
1076
N02BE01
ATC
paracetamol; systemic, rectal
2.0
12.3
708
6178
C02AC05
ATC
moxonidine; oral
3.7
12.3
53
149
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.7
12.2
375
2698
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.7
12.2
405
2980
WX408
NOMESCO Finland
General anesthesy, balanced
1.9
12.2
231
1427
L08.8
ICD-10 Finland
Other specified local infections of skin and subcutaneous tissue
5.2
12.1
37
74
XF400
NOMESCO Finland
ECG with 12 standard connections
2.1
12.1
154
819
L01AA01
ATC
cyclophosphamide; systemic
18.4
12.1
18
10
S81.9
ICD-10 Finland
Open wound of lower leg, part unspecified
11.3
12.1
22
20
SPAT1260
SPAT
Consultation of another employee
2.0
12.0
163
889
J45.9
ICD-10 Finland
Asthma, unspecified
2.1
12.0
159
857
B35.3
ICD-10 Finland
Tinea pedis
4.3
12.0
44
107
L03.9
ICD-10 Finland
Cellulitis, unspecified
5.8
11.9
33
59
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.6
11.8
93
391
A02BA02
ATC
ranitidine; systemic
2.0
11.7
176
1000
J01DA01
ATC
[U] cefalexin; systemic
1.7
11.6
509
4028
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.8
11.6
75
281
Z2221
NOMESCO Finland
Medical doctor
1.8
11.6
240
1525
103
Kela drug reimbursment
Diabetes, insulin-treated
1.8
11.6
228
1424
G47.3
ICD-10 Finland
Sleep apnoea
1.9
11.5
180
1036
A28
ICPC
Limited function/disability NOS
2.1
11.5
148
790
XF600
NOMESCO Finland
Bloodpressure measurement
2.9
11.5
71
260
L95
ICD-10 Finland
Vasculitis limited to skin, not elsewhere classified
+∞
11.5
11
*
E000006
ATC
NA
2.8
11.4
74
278
L30.3
ICD-10 Finland
Infective dermatitis
4.1
11.4
44
112
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
4.0
11.4
45
117
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
3.1
11.4
64
219
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.7
11.2
78
308
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.0
11.1
158
875
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
3.9
11.1
45
120
D69
ICD-10 Finland
Purpura and other haemorrhagic conditions
43.9
10.9
13
*
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.7
10.9
78
310
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.3
10.9
103
476
ZXD10
NOMESCO Finland
Scheduled procedure
1.7
10.8
319
2247
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.9
10.8
66
239
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
3.6
10.8
48
139
Z2446
NOMESCO Finland
Social worker
2.8
10.8
70
263
C08CA13
ATC
lercanidipine; oral
2.2
10.8
117
581
SPAT1262
SPAT
Handing over of treatment supplies
2.0
10.7
162
916
E000002
ATC
NA
2.3
10.7
102
476
A10AE05
ATC
insulin detemir; parenteral
3.1
10.7
60
205
PF1BT
NOMESCO Finland
Extensive PTA of arteries of knee, lower leg and ankle
60.8
10.6
12
*
S91.3
ICD-10 Finland
Open wound of other parts of foot
5.0
10.6
33
68
SPAT1263
SPAT
Sampling
1.7
10.6
346
2505
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
4.1
10.5
40
101
D07BC01
ATC
betamethasone and antiseptics; topical
2.2
10.4
112
554
QDB10
SPAT
NA
16.3
10.4
16
10
A06AD11
ATC
lactulose; oral
2.1
10.3
130
686
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.9
10.3
182
1090
L03.1
ICD-10 Finland
Cellulitis of other parts of limb
5.0
10.3
32
66
D07BA04
ATC
hydrocortisone and antiseptics; topical
2.4
10.3
92
415
NFQ20
NOMESCO Finland
Amputation of femur
19.1
10.3
15
8
ZX120
NOMESCO Finland
Intravenous
2.4
10.2
89
396
N02AJ06
ATC
codeine and paracetamol; systemic
1.7
10.1
290
2017
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.3
10.1
51
163
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.1
10.1
118
601
Z71.8
ICD-10 Finland
Other specified counselling
1.8
10.1
190
1164
A10BA02
ATC
metformin; oral
1.7
10.0
233
1525
S91.0
ICD-10 Finland
Open wound of ankle
7.8
9.9
22
29
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.3
9.9
92
421
TGC00
NOMESCO Finland
Bronchial lavation
4.5
9.9
34
78
R03BB04
ATC
tiotropium bromide; inhalant
2.3
9.9
92
423
C08DB01
ATC
diltiazem; oral
2.9
9.9
59
213
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.3
9.8
92
425
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.4
9.7
84
374
L17
ICPC
Foot/toe symptom/complaint
1.8
9.7
212
1358
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
5.0
9.7
30
62
A07EC01
ATC
sulfasalazine; oral, rectal
2.5
9.6
79
341
D02AE01
ATC
carbamide; topical
2.6
9.6
70
283
B01AB10
ATC
tinzaparin; parenteral
2.6
9.5
70
284
R06AE07
ATC
cetirizine; oral
1.6
9.5
339
2490
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
4.7
9.5
31
68
R06AX27
ATC
desloratadine; oral
1.8
9.4
204
1300
M05.2
ICD-10 Finland
Rheumatoid vasculitis
101.1
9.4
10
*
L94.0
ICD-10 Finland
Localized scleroderma [morphea]
+∞
9.4
9
*
WX892
NOMESCO Finland
Monitored bed care
2.5
9.4
75
319
B01AB04
ATC
dalteparin; parenteral
2.9
9.3
55
197
Z3226
NOMESCO Finland
Physiotherapist
1.9
9.3
159
938
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
4.1
9.2
35
89
SPAT1153
SPAT
Removal of sutures
1.7
9.2
259
1783
ZXE20
NOMESCO Finland
More than three and less than five hours
2.0
9.1
119
635
ZY010
NOMESCO Finland
Hospital outpatient
3.0
9.1
50
171
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
4.3
9.1
32
76
QDA99
NOMESCO Finland
Other local destruction of skin of lower limb
15.8
9.1
14
9
QDE35
NOMESCO Finland
Repair of skin defect in lower limb after surgery or injury
15.8
9.1
14
9
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
10.2
9.0
17
17
M10.9
ICD-10 Finland
Gout, unspecified
2.7
9.0
62
244
R4110
NOMESCO Finland
Physiotherapy
1.7
9.0
220
1452
J01MA14
ATC
moxifloxacin; systemic
2.3
9.0
81
368
M31.3
ICD-10 Finland
Wegener granulomatosis
18.8
8.9
13
7
A10AE04
ATC
insulin glargine; parenteral
2.3
8.9
88
415
NGQ20
NOMESCO Finland
Amputation of lower leg
24.3
8.9
12
5
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
8.9
273
1919
XW000
NOMESCO Finland
Bone marrow biopsy
3.2
8.8
45
146
J01FA06
ATC
roxithromycin; oral
1.6
8.8
323
2375
NG4AA
NOMESCO Finland
Lower leg X-ray examination
4.0
8.8
34
88
E66.8
ICD-10 Finland
Other obesity
3.2
8.8
45
147
R03DC03
ATC
montelukast; oral
1.9
8.8
131
735
M10.0
ICD-10 Finland
Idiopathic gout
3.9
8.7
34
89
M30.1
ICD-10 Finland
Polyarteritis with lung involvement [Churg-Strauss]
50.5
8.7
10
*
E11
ICD-10 Finland
Type 2 diabetes mellitus
1.9
8.6
134
766
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
3.9
8.6
34
90
XCW99
NOMESCO Finland
Other investigative procedure of eye
2.1
8.6
97
487
I50.1
ICD-10 Finland
Left ventricular failure
2.9
8.6
51
184
A10BB12
ATC
glimepiride; oral
2.5
8.6
68
290
R23.3
ICD-10 Finland
Spontaneous ecchymoses
4.6
8.5
28
62
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.6
8.5
320
2361
A12BA01
ATC
potassium chloride; oral
2.9
8.5
51
185
PD4BC
NOMESCO Finland
Extensive arterigography of lower extremity with X-ray
6.1
8.5
22
37
L27.0
ICD-10 Finland
Generalized skin eruption due to drugs and medicaments
6.1
8.5
22
37
T90
ICPC
Diabetes non-insulin dependent
1.7
8.5
187
1197
I50
ICD-10 Finland
Heart failure
3.2
8.5
42
134
J01AA02
ATC
doxycycline; systemic
1.6
8.5
610
5255
TPH07
NOMESCO Finland
Cathetrisation of artery
2.1
8.4
94
471
L88
ICPC
Rheumatoid/seropositive arthritis
3.3
8.4
41
129
M31.0
ICD-10 Finland
Hypersensitivity angiitis
90.9
8.4
9
*
S21
ICPC
Skin texture symptom/complaint
2.0
8.4
110
588
L84
ICD-10 Finland
Corns and callosities
4.2
8.3
30
73
L94.2
ICD-10 Finland
Calcinosis cutis
+∞
8.3
8
*
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
3.1
8.3
44
147
L14
ICPC
Leg/thigh symptom/complaint
2.3
8.3
74
335
P01AB01
ATC
metronidazole; oral, rectal
1.6
8.3
298
2177
XQ902
NOMESCO Finland
Other photography
14.6
8.2
13
9
NHQ30
NOMESCO Finland
Amputation of foot, transmetatarsal
14.6
8.2
13
9
A08
ICPC
Swelling
3.0
8.1
46
159
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
3.2
8.1
41
133
QDA10
NOMESCO Finland
Incision of skin of lower limb
11.8
8.1
14
12
M79.3
ICD-10 Finland
Panniculitis, unspecified
22.3
8.0
11
5
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.7
8.0
194
1272
R03AC02
ATC
salbutamol; inhalant
1.5
8.0
399
3136
S99
ICPC
Skin disease other
4.8
8.0
25
53
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.2
8.0
77
362
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.1
7.9
88
438
SPAT1255
SPAT
Intravenous administration of medicine
2.6
7.9
57
228
L03.0
ICD-10 Finland
Cellulitis of finger and toe
2.5
7.9
61
257
I73.0
ICD-10 Finland
Raynaud syndrome
6.2
7.9
20
33
A02BC05
ATC
esomeprazole; systemic
1.5
7.8
314
2343
L28
ICPC
Limited function/disability (L)
1.8
7.8
134
788
R07.4
ICD-10 Finland
Chest pain, unspecified
1.6
7.8
216
1468
N03.9
ICD-10 Finland
Chronic nephritic syndrome, unspecified
15.2
7.7
12
8
ZXA00
NOMESCO Finland
Right side
1.6
7.7
215
1463
N19
ICD-10 Finland
Unspecified kidney failure
3.3
7.7
36
111
ZX112
NOMESCO Finland
Subcutaneous
4.1
7.6
28
70
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
2.6
7.6
52
205
PE1AT
NOMESCO Finland
Femoral artery PTA
10.1
7.5
14
14
X59
ICD-10 Finland
Exposure to unspecified factor
1.8
7.5
151
934
C08CA02
ATC
felodipine; oral
2.1
7.5
86
437
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.8
7.5
140
849
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.7
7.5
188
1246
L59.9
ICD-10 Finland
Disorder of skin and subcutaneous tissue related to radiation, unspecified
80.8
7.4
8
*
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.8
7.4
147
908
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
3.0
7.4
40
137
A01AB09
ATC
miconazole; local oral
2.1
7.4
80
396
ZXA10
NOMESCO Finland
Bilateral
1.7
7.3
154
966
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.8
7.3
130
773
DHA10
NOMESCO Finland
Biopsy of cavity of nose
8.5
7.3
15
18
C08CA01
ATC
amlodipine; oral
1.5
7.3
282
2077
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.7
7.3
146
903
C09AA05
ATC
ramipril; oral
1.6
7.3
203
1381
D89.1
ICD-10 Finland
Cryoglobulinaemia
+∞
7.3
7
*
QC6S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in hand
+∞
7.3
7
*
A18.4
ICD-10 Finland
Tuberculosis of skin and subcutaneous tissue
+∞
7.3
7
*
UKC02
NOMESCO Finland
Cystoscopy
1.8
7.3
133
800
C09AA02
ATC
enalapril; systemic
1.7
7.3
161
1028
R11
ICD-10 Finland
Nausea and vomiting
2.2
7.3
70
329
PD4DE
NOMESCO Finland
Lower extremity artery ultrasound examination with Doppler method
5.5
7.3
20
37
N08.2
ICD-10 Finland
Glomerular disorders in blood diseases and disorders involving the immune mechanism
15.9
7.2
11
7
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
3.5
7.2
32
95
K07
ICPC
Swollen ankles/oedema
2.7
7.1
47
182
L50.3
ICD-10 Finland
Dermatographic urticaria
5.1
7.1
21
42
WX212
NOMESCO Finland
Femoral plexus blockade
4.6
7.1
23
51
Z01.8
ICD-10 Finland
Other specified special examinations
1.7
7.1
164
1058
RJ411
NOMESCO Finland
NA
12.2
7.1
12
10
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.3
7.1
66
304
D01AE15
ATC
terbinafine; topical
2.4
7.0
59
261
A02BC03
ATC
lansoprazole; oral
1.6
7.0
224
1573
C01DA14
ATC
isosorbide mononitrate; oral
1.8
7.0
132
802
L40.0
ICD-10 Finland
Psoriasis vulgaris
2.9
7.0
41
148
TQW99
NOMESCO Finland
Other minor procedure on skin
2.7
7.0
46
179
PD4AC
NOMESCO Finland
Arterigography of lower extremity with X-ray
5.9
6.9
18
31
H02AB04
ATC
methylprednisolone; systemic
1.8
6.9
117
687
A10BJ06
ATC
semaglutide; parenteral
3.6
6.9
29
82
JN4BD
NOMESCO Finland
Extensive body CT
2.0
6.9
93
501
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.5
6.9
51
208
QDB99
NOMESCO Finland
Other procedure for wound of skin of lower limb
13.9
6.9
11
8
C08CA05
ATC
nifedipine; systemic
2.4
6.8
57
250
SPAT1225
SPAT
Implementation of podiatry rehabilitation plan
3.6
6.8
29
83
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
2.1
6.8
76
379
L50.1
ICD-10 Finland
Idiopathic urticaria
11.0
6.8
12
11
D72.1
ICD-10 Finland
Eosinophilia
11.0
6.8
12
11
I80.3
ICD-10 Finland
Phlebitis and thrombophlebitis of lower extremities, unspecified
2.8
6.8
41
151
XQ800
NOMESCO Finland
Prick test
2.3
6.8
59
263
S19
ICPC
Skin injury other
2.9
6.8
39
138
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
2.8
6.8
40
145
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
16.8
6.8
10
6
A10BB01
ATC
glibenclamide; oral
2.8
6.7
40
146
E11.6
ICD-10 Finland
Type 2 diabetes mellitus, with other specified complications
5.0
6.7
20
41
A10BH01
ATC
sitagliptin; oral
2.1
6.7
77
390
WX722
NOMESCO Finland
PEEP
2.7
6.7
44
171
SPAT1254
SPAT
Administration of medicine
1.8
6.7
123
743
UJF92
NOMESCO Finland
Capsular endoscopy
5.2
6.7
19
37
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
3.6
6.6
28
80
ED1AA
NOMESCO Finland
Mandipular X-ray examination
12.4
6.6
11
9
M86.9
ICD-10 Finland
Osteomyelitis, unspecified
12.4
6.6
11
9
AA1AD
NOMESCO Finland
CT of head and brain
1.6
6.6
190
1302
160
Kela drug reimbursment
exenatide
4.2
6.5
23
56
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.6
6.5
173
1159
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.5
6.5
252
1848
N06AX21
ATC
duloxetine; oral
2.0
6.5
84
447
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
3.2
6.5
31
98
4019X
ICD-9 Finland
Essential hypertension, Unspecified
3.3
6.4
30
93
L93.0
ICD-10 Finland
Discoid lupus erythematosus
70.4
6.4
7
*
QD6S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in foot
70.4
6.4
7
*
M36.4*D69.0
ICD-10 Finland
Arthropathy in Henoch(-Schönlein) purpura
70.4
6.4
7
*
RJ412
NOMESCO Finland
NA
70.4
6.4
7
*
ZX108
NOMESCO Finland
Inhalation
7.5
6.4
14
19
L73.2
ICD-10 Finland
Hidradenitis suppurativa
7.5
6.4
14
19
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.6
6.4
170
1138
TQW40
NOMESCO Finland
Remowal of suture of skin
2.2
6.4
59
273
R60.9
ICD-10 Finland
Oedema, unspecified
2.6
6.3
45
182
QCB05
NOMESCO Finland
Revision of wound of skin of upper limb
11.1
6.3
11
10
D07XC01
ATC
betamethasone, combinations; topical
1.9
6.3
92
512
WX002
NOMESCO Finland
Sedation and analgesia
1.6
6.3
156
1026
M30
ICD-10 Finland
Polyarteritis nodosa and related conditions
+∞
6.3
6
*
R03DX05
ATC
omalizumab; parenteral
+∞
6.3
6
*
L98.1
ICD-10 Finland
Factitial dermatitis
+∞
6.3
6
*
G63.2*E10.4
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic polyneuropathy
+∞
6.3
6
*
L94.8
ICD-10 Finland
Other specified localized connective tissue disorders
+∞
6.3
6
*
M05BA07
ATC
risedronic acid; oral
2.8
6.2
37
135
E66.00
ICD-10 Finland
Metabolic syndrome
2.5
6.2
47
195
D07AA02
ATC
hydrocortisone; topical
1.8
6.2
102
590
XG466
NOMESCO Finland
Sleep oxymetry
3.1
6.2
32
107
J01CE02
ATC
phenoxymethylpenicillin; oral
1.4
6.2
515
4400
WX320
NOMESCO Finland
Spinalanesthesy
1.6
6.1
173
1175
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.7
6.1
129
809
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.7
6.1
135
859
XQ858
NOMESCO Finland
Oxygen partial pressure measurement
6.8
6.0
14
21
C01AA05
ATC
digoxin; systemic
2.0
6.0
71
366
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
5.2
6.0
17
33
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.7
6.0
125
779
X57
ICD-10 Finland
Unspecified privation
3.7
6.0
24
66

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40768443) Skin Pathology biopsy report
308
274
16.45
312.27
1.5
1.2
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
303
198
22.40
307.65
1.8
1.5
g/l
0.2
0.2
0.15
291
190
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
305
236
18.90
307.65
1.9
1.6
titre
98.6
210.0
—
14
10
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
303
205
21.61
307.65
1.8
1.5
g/l
1.2
1.2
1.08
291
196
(3009445) Proteinase 3 Ab [Units/volume] in Serum
363
297
19.62
307.65
1.9
1.4
u/ml
34.1
8.8
—
9
8
(3015171) Extractable nuclear Ab [Units/volume] in Serum
259
233
15.12
258.24
1.4
1.2
u/ml
1.5
2.3
0.17
18
12
(3037522) Nuclear Ab [Titer] in Serum
424
908
7.84
209.53
1.7
1.3
titre
559.7
482.3
0.32
116
192
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
158
121
15.58
170.67
1.6
1.3
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
160
208
9.11
119.21
2.6
1.8
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
298
804
5.02
105.70
3.6
1.5
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
232
511
5.74
104.08
2.1
2.5
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
253
611
5.34
102.11
2.4
2.8
g/l
67.1
66.4
0.68
235
550
(3006315) Basophils [#/volume] in Blood
694
3657
4.73
95.93
12.1
5.6
e9/l
0.0
0.0
0.93
640
3160
(3001604) Monocytes [#/volume] in Blood
692
3646
4.70
95.48
12.1
5.6
e9/l
0.6
0.6
3.04
637
3141
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
100
92
12.08
95.33
1.4
1.2
u/ml
2.0
4.9
0.61
41
30
(3019198) Lymphocytes [#/volume] in Blood
696
3746
4.60
91.57
12.2
5.7
e9/l
1.8
1.9
0.60
641
3283
(3013115) Eosinophils [#/volume] in Blood
701
3798
4.63
91.22
12.4
5.9
e9/l
0.2
0.2
0.34
647
3325
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
127
171
8.46
91.20
1.3
1.2
u/ml
4.0
12.9
0.65
19
26
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
125
170
8.36
88.96
1.3
1.2
u/ml
10.0
2.7
0.49
11
17
(3022096) Basophils/100 leukocytes in Blood
645
3363
4.12
86.95
12.5
5.8
%
0.6
0.7
1.92
626
3122
(3006504) Eosinophils/100 leukocytes in Blood
653
3465
4.10
84.99
12.5
5.8
%
2.6
2.9
2.41
633
3212
(42870588) Differential panel, method unspecified - Blood
536
2503
3.76
84.66
10.5
5.6
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
652
3487
4.03
83.12
12.8
6.1
%
8.4
8.7
1.08
631
3255
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
109
136
8.96
83.12
1.3
1.2
u/ml
1.3
9.7
—
5
10
(3002030) Lymphocytes/100 leukocytes in Blood
657
3569
3.99
80.92
12.6
5.9
%
24.4
27.5
11.10
635
3312
(3018010) Neutrophils/100 leukocytes in Blood
651
3519
3.95
80.69
11.8
5.7
%
61.2
57.6
12.13
628
3284
(3036481) Cortisol [Moles/volume] in Serum or Plasma
236
677
4.35
74.98
2.9
2.0
nmol/l
317.7
374.7
4.13
222
621
(3013650) Neutrophils [#/volume] in Blood by Automated count
718
4292
4.14
73.14
15.1
8.9
e9/l
4.8
4.1
7.21
665
3755
(3017143) Hepatitis C virus Ab [Presence] in Serum
243
727
4.19
72.75
1.6
1.5
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
85
97
9.56
69.24
1.4
1.2
u/ml
2.4
6.4
1.04
39
44
(3005719) IgG [Mass/volume] in Serum or Plasma
201
542
4.47
68.85
4.3
2.7
g/l
11.1
10.7
0.41
188
490
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
69
59
12.57
68.57
1.3
1.2
titre
134.0
110.0
—
15
9
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
139
284
5.59
66.24
2.3
2.4
g/l
4.3
3.7
3.83
111
209
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
139
285
5.57
65.97
2.3
2.4
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
139
285
5.57
65.97
2.3
2.4
g/l
7.4
7.4
0.09
112
216
(3028026) IgM [Mass/volume] in Serum or Plasma
174
438
4.67
64.84
2.1
1.6
g/l
1.3
1.4
0.46
157
399
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
94
132
7.82
64.63
1.3
1.2
u/ml
39.7
43.6
—
11
7
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
124
241
5.80
62.26
2.6
2.7
g/l
0.6
0.9
0.47
112
212
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
130
265
5.55
61.97
2.3
2.5
g/l
3.2
3.2
0.04
112
213
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
519
2720
3.10
61.39
5.5
3.1
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
117
218
6.01
61.39
2.4
2.6
g/l
0.0
0.0
0.10
111
201
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
129
267
5.46
60.42
2.3
2.5
g/l
10.8
10.4
0.48
121
231
(3000850) Epithelial cells [#/volume] in Urine
370
1619
3.16
59.94
4.3
2.4
e6/l
5.4
6.0
0.31
342
1440
(3021440) Promyelocytes/100 leukocytes in Blood
198
587
4.03
59.08
6.9
4.1
%
0.1
0.1
0.13
72
164
(3017181) Myelocytes/100 leukocytes in Blood
203
621
3.92
57.85
6.9
4.0
%
0.9
0.8
0.29
76
180
(4306422)
72
84
9.22
57.51
1.3
1.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
357
1574
3.08
56.45
9.6
4.3
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
278
1061
3.33
56.23
3.2
1.9
—
—
—
0
0
(3026782) Osmolality of Urine
345
1522
3.03
54.08
4.4
2.8
mosm/kgh2o
511.6
551.1
3.33
317
1314
(3002179) Metamyelocytes/100 leukocytes in Blood
186
560
3.91
53.98
6.4
3.9
%
0.5
0.5
0.13
59
128
(3021879) Hepatitis B virus core Ab [Presence] in Serum
169
477
4.12
53.67
1.4
1.4
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
184
552
3.92
53.65
7.2
4.1
%
0.0
0.1
0.09
61
138
(3021589) Normoblasts [#/volume] in Blood
568
3291
2.92
53.17
20.6
9.2
e9/l
0.0
0.0
0.10
504
2701
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
228
794
3.49
53.13
6.3
3.3
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
421
2098
2.87
52.32
5.2
3.0
e6/l
0.3
0.5
2.55
367
1591
(3002582) Erythrocytes [#/volume] in Urine
448
2307
2.85
52.29
5.4
3.1
e6/l
82.0
88.5
0.04
397
1793
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
105
206
5.63
51.94
2.6
2.7
g/l
0.0
0.0
0.50
99
189
(3023368) Bacteria identified in Blood by Culture
416
2073
2.85
51.52
7.5
4.0
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
195
626
3.69
51.35
2.7
2.4
e9/l
77.4
70.5
1.38
146
491
(3027945) Reticulocytes/100 erythrocytes in Blood
233
848
3.35
50.34
3.3
2.5
%
2.0
1.8
1.49
208
744
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
101
197
5.64
50.24
2.1
2.5
%
97.8
91.1
1.67
96
183
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
69
91
8.12
49.85
1.2
1.1
—
—
—
0
0
(4268621)
59
66
9.49
48.56
2.7
2.3
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
108
231
5.17
48.43
2.5
2.6
g/l
37.1
37.4
0.17
102
199
(3018095) Leukocytes [#/volume] in Urine
484
2674
2.72
48.06
6.3
3.7
e6/l
80.1
105.9
0.28
413
1919
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
34
14
25.19
47.96
1.1
1.1
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
404
2046
2.75
47.60
5.2
3.0
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
236
894
3.21
47.44
1.6
1.6
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
251
992
3.11
46.86
3.4
2.4
%
20.3
22.3
1.37
225
845
(3003458) Phosphate [Moles/volume] in Serum or Plasma
249
980
3.12
46.82
7.0
5.0
mmol/l
1.1
1.0
1.38
236
894
(46235355) HIV 1 and 2 tests - Meaningful Use set
264
1081
3.03
46.24
1.9
1.8
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
544
3246
2.67
45.30
7.6
4.7
g/l
33.8
35.4
9.16
524
3008
(3022948) Iron [Moles/volume] in Serum or Plasma
273
1157
2.94
44.75
3.2
2.3
umol/l
11.1
12.8
3.55
259
1069
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
29
10
29.92
43.36
1.2
1.2
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
212
796
3.17
42.86
4.3
4.0
u/l
241.1
252.9
0.42
203
750
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
89
182
5.31
41.88
2.0
2.8
%
204.6
194.6
0.40
83
175
(3004789) Transferrin [Mass/volume] in Serum or Plasma
253
1063
2.91
41.79
3.3
2.3
g/l
2.3
2.3
1.56
238
984
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
193
697
3.24
41.57
2.6
2.3
g/l
0.2
0.2
0.45
181
652
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
30
13
23.83
41.42
1.2
1.1
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
177
627
3.26
39.21
7.7
6.8
mmol/l
11.4
10.0
1.51
168
594
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
269
1211
2.73
38.57
1.3
1.3
iu/ml
33.4
34.9
0.09
80
382
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
37
29
13.25
38.50
1.1
1.1
ratio
1.0
1.1
—
19
10
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
90
200
4.88
38.41
2.5
1.6
—
—
—
0
0
(3036489) Thrombin time
100
244
4.48
38.03
2.2
2.3
s
21.3
21.3
0.02
87
219
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
91
208
4.75
37.52
1.4
1.3
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
82
174
5.08
36.92
1.3
1.7
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
748
5533
2.94
35.93
8.4
4.0
mm/h
18.5
12.6
14.83
713
5092
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
52
72
7.60
35.92
1.5
1.1
u/ml
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
263
1208
2.65
35.90
3.8
3.2
mmol/l
0.8
0.8
5.05
246
1133
(40758558) Short blood count panel - Blood
345
1859
2.37
32.90
10.3
6.7
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
581
3913
2.33
32.44
8.2
6.1
umol/l
11.0
11.6
0.68
564
3700
(3030905) Polymorphonuclear cells [#/volume] in Blood
68
137
5.28
32.42
5.3
3.1
e9/l
4.8
4.2
0.99
68
137
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
346
1889
2.34
31.79
3.1
2.2
mg/l
3.4
3.1
1.17
312
1581
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
68
140
5.17
31.63
5.6
3.3
%
61.6
57.5
1.64
68
140
(3032080) INR in Blood by Coagulation assay
490
3096
2.26
31.62
16.5
9.7
inr
1.3
1.3
0.17
202
883
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
563
3773
2.28
31.36
9.2
6.5
mmol/l
1.2
1.2
0.79
450
3174
(3026493) Urate [Moles/volume] in Serum or Plasma
344
1884
2.32
31.27
3.7
2.6
umol/l
4135.0
8096.8
0.97
308
1616
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
527
3445
2.25
31.09
8.1
5.8
mmol/l
1.2
1.2
0.80
476
3100
(3035350) Ketones [Presence] in Urine by Test strip
551
3671
2.26
30.98
5.9
3.6
estimate
0.0
0.0
0.00
188
693
(3018418) pH of Serum or Plasma
389
2250
2.27
30.98
6.4
3.7
ph
7.4
7.4
1.04
111
422
(3017817) Protein [Mass] in Urine collected for unspecified duration
46
66
7.29
30.76
1.8
2.4
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
65
132
5.22
30.70
1.3
1.2
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
102
296
3.75
30.49
1.7
2.1
u/l
38.5
38.5
0.01
83
263
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
483
3083
2.20
29.78
3.0
2.2
nmol/l
77.4
77.4
0.01
443
2729
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
753
5802
2.69
29.40
13.5
7.3
u/l
81.7
78.3
1.51
731
5423
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
23
12
19.64
29.27
1.1
1.0
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
544
3676
2.19
28.57
7.4
5.0
estimate
0.0
0.0
0.50
196
696
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
34
37
9.51
28.41
1.3
1.2
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
252
1252
2.40
28.21
2.3
1.8
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
547
3718
2.17
28.12
6.0
3.7
estimate
0.0
0.0
0.50
185
670
(40761536) Microorganisms panel - Urine sediment
158
633
2.81
27.56
7.2
3.7
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
484
3161
2.13
27.32
3.9
2.7
ug/l
171.4
132.9
1.12
451
2887
(3037467) Urinalysis macro (dipstick) panel - Urine
691
5197
2.35
27.09
7.6
4.3
—
—
—
0
0
(3012501) Base excess in Blood by calculation
66
151
4.63
27.07
6.2
4.6
mmol/l
3.2
2.6
0.65
51
98
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
142
543
2.91
26.98
2.3
1.5
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
265
1389
2.28
25.90
1.9
1.5
g/l
3.3
2.5
3.75
205
825
(3029937) Albumin [Presence] in Urine by Test strip
341
1982
2.15
25.73
6.9
3.9
estimate
0.0
0.0
0.69
189
667
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
94
294
3.45
25.00
2.7
1.9
ug/l
3.5
2.8
0.20
85
257
(1616796) Gas panel - Central venous blood
63
149
4.47
24.78
6.0
3.5
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
72
189
4.05
24.71
3.9
4.0
mg/l
1.8
1.6
0.68
67
171
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
372
2286
2.06
23.77
2.7
2.1
u/l
141.0
248.1
2.23
348
2153
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
81
238
3.64
23.67
3.3
3.7
ratio
2.4
1.9
0.20
11
23
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
82
243
3.61
23.66
3.3
3.8
mg/l
34.3
49.7
0.60
65
199
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
71
191
3.95
23.55
1.8
2.2
mg/l
11.1
12.2
0.45
64
176
(3034860) Kappa light chains.free [Mass/volume] in Serum
81
242
3.58
23.08
3.3
3.8
mg/l
55.4
82.4
0.49
64
197
(3004616) Nuclear Ab [Presence] in Serum
42
75
5.82
22.75
1.4
1.3
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
656
4986
2.12
22.68
7.1
4.6
e6/l
9.0
2969.4
—
7
84
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
82
253
3.46
22.24
2.2
1.9
ug/l
244.0
423.3
0.49
72
237
(3013826) Glucose [Moles/volume] in Serum or Plasma
601
4444
2.03
22.13
6.4
4.7
mmol/l
7.0
6.7
1.88
579
4164
(3005322) IgE [Units/volume] in Serum or Plasma
118
453
2.84
22.08
1.6
1.2
u/ml
281.7
271.3
0.04
112
411
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
96
328
3.15
22.08
1.5
2.0
g/l
1.5
1.5
0.25
81
287
(3012516) Albumin [Mass/volume] in Urine
357
2219
2.00
21.61
4.1
3.1
mg/l
455.5
290.9
0.27
248
1369
(40767503) Oxygen content in Capillary blood by calculation
59
149
4.16
21.31
4.5
2.1
%
15.8
15.7
0.06
30
76
(3024980) IgG subclass 4 [Mass/volume] in Serum
47
101
4.85
20.76
1.7
1.8
g/l
0.8
0.9
0.11
30
79
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
73
219
3.54
20.65
1.6
1.6
iu/ml
0.2
0.1
0.50
23
48
(3026008) Bacteria identified in Urine by Culture
373
2384
1.95
20.58
4.5
3.2
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
362
2293
1.96
20.49
4.1
3.1
ng/l
1814.3
1409.3
1.10
323
1943
(3027135) IgG subclass 1 [Mass/volume] in Serum
35
58
6.23
20.42
1.4
1.2
g/l
5.7
7.8
1.48
21
40
(3028192) IgG subclass 2 [Mass/volume] in Serum
35
58
6.23
20.42
1.4
1.2
g/l
2.7
2.8
0.04
21
39
(3024139) IgG subclass 3 [Mass/volume] in Serum
35
58
6.23
20.42
1.4
1.2
g/l
0.3
0.5
0.75
21
39
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
142
626
2.50
20.11
5.4
3.5
mmol/l
1.2
1.2
0.88
129
541
(3009508) Creatinine [Moles/volume] in Urine
369
2364
1.94
20.10
4.3
3.0
mmol/l
6.9
7.5
2.06
320
1965
(3020682) Albumin/Creatinine [Ratio] in Urine
367
2348
1.94
20.06
5.5
3.8
mg/mmol
16.6
8.7
1.68
265
1457
(4062490)
35
60
6.03
19.75
1.4
1.2
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
278
1626
2.02
19.63
1.9
1.7
mg/l
1.2
1.2
0.24
232
1237
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
177
870
2.28
19.59
2.2
1.7
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
33
54
6.30
19.49
1.3
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
33
54
6.30
19.49
1.3
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
33
54
6.30
19.49
1.3
1.2
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
176
869
2.27
19.25
2.2
1.8
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
33
55
6.19
19.14
1.3
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
33
55
6.19
19.14
1.3
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
33
55
6.19
19.14
1.3
1.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
75
244
3.26
18.67
4.0
2.6
u/ml
0.3
0.4
1.05
47
133
(3041096) Erythrocytes [Presence] in Urine by Automated
322
2014
1.92
18.51
5.2
3.4
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
391
2609
1.87
18.37
4.0
3.3
mmol/l
2.3
2.4
0.88
347
2264
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
28
41
7.01
18.33
2.3
1.7
%
12.4
11.7
—
10
19
(3011412) CD3 cells [#/volume] in Blood
33
58
5.87
18.15
2.9
1.7
e9/l
1.1
1.1
0.10
22
30
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
360
2347
1.88
18.13
3.3
2.5
u/l
52.3
57.4
2.31
330
2157
(3021960) Folate [Moles/volume] in Serum or Plasma
301
1852
1.93
18.10
1.9
1.5
nmol/l
19.8
21.0
0.59
258
1548
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
217
1198
2.06
17.73
4.0
2.9
e6/l
3.6
2.6
0.72
139
653
(40760888) Immunoglobulin light chains.free panel - Serum
60
179
3.52
17.11
3.5
4.0
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
45
112
4.17
16.56
1.1
1.1
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
299
1881
1.88
16.52
6.0
3.8
%
85.7
89.5
1.46
291
1831
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
130
605
2.34
16.18
5.3
3.5
ng/l
98.1
82.0
1.14
116
525
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
207
1158
2.02
16.15
1.4
1.3
u/ml
13.2
12.4
0.05
74
423
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
409
2852
1.79
15.99
6.4
3.8
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
412
2882
1.78
15.92
2.3
2.1
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
18
18
10.18
15.85
1.4
1.3
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
25
38
6.74
15.81
2.6
1.7
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
144
711
2.22
15.55
5.6
3.8
mmol/l
1.8
2.1
0.54
123
563
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
219
1267
1.96
15.45
3.9
2.7
e6/l
0.8
1.2
1.24
139
716
(3000494) Fungus identified in Specimen by Culture
169
899
2.08
15.05
1.8
1.4
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
244
1483
1.88
14.75
2.0
1.7
nmol/l
1357.5
1178.2
2.06
198
1106
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
54
166
3.39
14.71
1.6
1.5
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
99
426
2.48
14.62
1.7
1.5
—
—
—
0
0
(3034426) Prothrombin time (PT)
19
23
8.42
14.54
1.3
1.3
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
36
84
4.42
14.40
1.3
1.7
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
17
19
9.10
13.81
1.3
1.1
g/l
0.3
0.3
1.13
12
14
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
46
134
3.56
13.61
1.3
1.2
u/ml
281.5
249.3
0.25
24
77
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
28
56
5.13
13.43
1.3
1.7
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
17
20
8.64
13.28
2.5
1.5
—
—
—
0
0
(3000991) Gas panel - Venous blood
127
638
2.15
13.04
7.3
8.0
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
46
138
3.46
13.02
4.8
2.5
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
68
257
2.78
13.01
2.8
3.0
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
46
139
3.43
12.88
1.2
1.2
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
169
950
1.96
12.75
7.0
6.5
mmol/l
103.8
104.3
0.60
163
922
(3042111) Morphology [Interpretation] in Bone marrow Narrative
43
126
3.53
12.61
1.5
1.6
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
39
107
3.76
12.59
1.1
1.0
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
38
103
3.81
12.48
1.4
1.6
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
57
201
2.96
12.38
5.2
2.8
mmol/l
25.1
25.0
0.09
52
175
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
345
2419
1.68
12.36
3.6
3.2
u/l
42.8
32.6
0.77
314
2299
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
59
213
2.89
12.29
1.3
1.1
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
60
222
2.82
11.95
3.4
3.1
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
40
116
3.56
11.92
3.7
3.4
%
1.2
1.4
0.16
32
92
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
41
121
3.50
11.91
1.4
1.4
u/ml
110.2
111.8
0.05
14
15
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
43
132
3.37
11.76
1.5
1.6
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
43
133
3.34
11.62
1.3
1.4
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
42
128
3.39
11.62
2.9
2.5
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
52
181
2.99
11.56
1.3
1.6
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
103
501
2.19
11.43
5.5
3.6
kpa
5.3
5.2
0.68
97
469
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
13
13
10.13
11.36
1.2
1.1
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
153
864
1.93
11.31
2.9
2.7
umol/l
8.7
8.1
0.16
129
738
(3009343) pH of Capillary blood
102
497
2.18
11.27
5.4
3.6
ph
7.4
7.4
0.24
26
54
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
50
173
3.00
11.24
1.4
1.6
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
22
42
5.34
11.10
2.7
1.7
e6/l
420.1
506.6
0.37
17
34
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
22
42
5.34
11.10
1.8
1.7
u/l
6.7
8.7
0.15
14
24
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
98
473
2.20
11.08
5.5
3.6
mmol/l
2.3
2.0
0.33
79
356
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
126
672
2.01
10.97
2.4
2.3
u/l
44.6
35.3
0.46
114
570
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
49
170
2.99
10.96
1.4
1.6
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
30
76
4.05
10.82
1.1
1.3
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
82
371
2.33
10.81
5.9
4.2
mmol/l
23.7
24.4
1.10
76
339
(3048689) Calprotectin [Mass/mass] in Stool
150
857
1.90
10.67
3.0
2.3
ug/g
117.9
139.6
0.52
119
670
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
14
17
8.35
10.63
2.8
1.6
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
415
3140
1.59
10.46
2.3
2.0
pmol/l
92.0
94.4
0.44
241
1598
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
29
74
4.01
10.36
1.3
1.2
u/l
45.9
51.1
0.34
23
58
(3003396) Base excess in Arterial blood by calculation
151
883
1.85
9.96
6.1
7.6
mmol/l
1.3
1.3
0.04
113
684
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
583
4808
1.59
9.89
4.4
3.1
u/l
66.7
48.8
4.13
537
4462
(3000093) Morphology [Interpretation] in Blood Narrative
27
68
4.06
9.82
1.1
1.1
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
448
3484
1.56
9.81
5.3
4.0
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
249
1685
1.66
9.80
5.9
3.6
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
224
1476
1.69
9.76
3.2
3.1
mmol/l
2.5
2.5
2.78
202
1299
(3048929) Epstein Barr virus Ab [Presence] in Serum
55
220
2.60
9.45
1.3
1.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
143
835
1.84
9.45
1.4
1.3
—
—
—
0
0
(3019060) Gas panel - Arterial blood
99
510
2.06
9.45
4.9
5.5
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
390
2959
1.55
9.41
5.9
3.7
ng/l
48.5
47.3
0.02
299
2083
(3009871) Measles virus Ab [Titer] in Serum
12
14
8.67
9.36
1.7
1.6
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
43
152
2.92
9.34
1.5
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
43
152
2.92
9.34
1.5
1.3
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
34
105
3.32
9.24
3.2
2.3
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
33
100
3.39
9.24
1.3
1.5
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
216
1428
1.67
9.24
4.7
4.0
ng/l
243.1
328.7
0.28
177
1140
(3022217) INR in Platelet poor plasma by Coagulation assay
163
999
1.77
9.17
28.9
25.3
inr
1.5
1.3
0.43
28
130
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
242
1655
1.63
9.03
2.0
1.7
pmol/l
438.8
23486940.5
1.42
202
1371
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
36
118
3.13
8.90
1.5
1.3
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
164
1015
1.75
8.90
1.4
1.2
—
—
—
0
0
(3020891) Body temperature
65
291
2.33
8.79
4.4
4.4
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
147
885
1.79
8.76
6.2
7.6
kpa
5.0
5.1
0.32
137
844
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
38
131
2.98
8.63
1.2
1.2
u/l
82.7
41.3
0.44
29
117
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
819
7464
1.94
8.61
35.0
14.1
mg/l
21.9
24.2
1.69
750
5891
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
11
13
8.55
8.47
1.0
1.2
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
146
886
1.77
8.46
6.2
7.6
kpa
11.7
12.1
0.66
137
846
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
663
5729
1.57
8.36
4.5
3.9
pmol/l
15.1
14.8
1.29
595
5160
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
115
654
1.87
8.23
3.7
3.1
ng/l
239.6
218.3
0.23
105
603
(3037121) Protein [Mass/volume] in Urine
63
288
2.28
8.13
4.2
3.1
g/l
0.3
0.2
0.58
32
115
(3023183) Ammonium ion [Moles/volume] in Plasma
44
170
2.67
8.13
3.7
3.2
umol/l
33.9
34.6
0.07
34
141
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
103
568
1.92
8.10
4.8
2.6
ml/min/173m2
59.6
66.3
0.98
57
241
(4035726)
112
636
1.87
8.05
1.5
1.4
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
40
148
2.78
8.02
1.6
1.6
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
38
137
2.85
7.99
1.4
1.3
mmol/l
58.9
60.2
0.07
33
110
(3044640) Blood type and Crossmatch panel - Blood
317
2368
1.52
7.87
3.4
2.4
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
20
48
4.24
7.76
2.8
1.9
e6/l
861.1
847.7
—
9
20
(40761535) Cells panel - Urine sediment
106
599
1.87
7.73
6.3
3.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
227
1585
1.57
7.61
1.3
1.2
u/ml
1.7
1.8
0.01
75
420
(44806071)
10
12
8.41
7.59
1.0
1.1
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
12
9
13.49
7.39
1.4
2.0
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
13
22
5.98
7.39
1.1
1.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
32
110
2.98
7.34
1.3
1.5
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
35
127
2.83
7.29
1.3
1.5
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
129
793
1.73
7.11
6.7
8.0
%
96.2
95.5
1.45
124
760
(3002385) Erythrocyte distribution width [Ratio]
695
6156
1.54
7.03
38.2
17.6
%
14.3
13.7
16.90
688
6021
(21494434) Karyotype in Bone marrow
24
71
3.44
7.01
1.1
1.2
—
—
—
0
0
(3004451) EKG impression Narrative
17
40
4.31
6.77
1.4
1.2
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
29
99
2.99
6.74
1.3
1.5
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
23
69
3.39
6.58
1.2
1.2
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
76
406
1.95
6.57
5.9
9.0
mmol/l
24.4
24.6
0.25
70
379
(3002256) Pathology report gross observation
143
924
1.65
6.53
1.3
1.3
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
83
458
1.89
6.52
2.4
1.6
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
43
185
2.39
6.41
1.4
1.2
titre
218.6
68.8
—
7
17
(3035637) Corticotropin [Mass/volume] in Plasma
25
81
3.15
6.35
1.4
1.6
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
16
38
4.27
6.30
1.5
1.6
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
13
26
5.06
6.24
1.1
1.0
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
13
26
5.06
6.24
4.5
3.5
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
23
72
3.25
6.18
1.3
2.3
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
26
88
3.01
6.15
2.6
1.5
%
53.7
59.9
0.27
14
64
(3006184) Hemoglobin [Mass/volume] in Capillary blood
40
170
2.41
6.13
4.4
2.0
g/l
125.3
125.9
0.05
35
122
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
16
39
4.16
6.10
1.5
1.6
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
35
141
2.54
6.00
2.3
1.5
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
16
40
4.05
5.91
1.4
1.2
u/l
5.2
8.1
0.82
16
33
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
45
207
2.23
5.78
1.9
1.3
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
43
197
2.24
5.59
1.3
1.2
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
14
33
4.29
5.57
1.0
1.3
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
8
5
16.13
5.41
1.0
1.0
—
—
—
0
0
(3016750) Collection duration of Urine
17
48
3.59
5.34
1.4
2.3
min
531.3
494.7
0.42
12
32
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
17
48
3.59
5.34
1.5
1.5
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
29
114
2.59
5.25
1.1
1.1
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
19
59
3.27
5.19
1.4
2.4
ml
755.0
635.6
0.36
13
37
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
753
6921
1.50
5.12
7.2
5.8
mmol/mol
41.5
39.9
3.71
703
6374
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
746
6856
1.48
4.96
5.5
4.7
mu/l
2.1
1.9
0.65
684
6210
(3013512) EKG study
285
2251
1.39
4.79
5.0
4.0
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
10
20
5.04
4.78
3.6
1.5
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
15
42
3.61
4.78
3.3
4.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
165
1188
1.47
4.61
1.5
1.5
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
236
1816
1.40
4.60
3.3
2.3
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
7
5
14.09
4.58
1.3
1.0
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
10
21
4.80
4.54
1.1
1.1
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
10
21
4.80
4.54
1.2
1.2
—
—
—
0
0
(40768441) Liver Pathology biopsy report
18
59
3.09
4.53
1.2
1.5
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
20
70
2.90
4.51
2.5
1.6
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
23
87
2.69
4.51
1.3
1.3
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
39
190
2.10
4.41
2.2
2.4
ug/min
157.5
56.1
0.83
21
113
(4027681)
13
35
3.75
4.37
1.2
1.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
13
35
3.75
4.37
1.4
1.1
—
—
—
0
0
(3044889) 12 lead EKG panel
594
5295
1.35
4.37
5.3
3.8
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
29
127
2.33
4.23
2.1
1.3
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
62
360
1.77
4.20
5.4
3.1
mmol/l
25.3
25.2
0.15
62
353
(3000012) Reticulocyte production index
15
47
3.23
4.07
1.9
1.5
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
12
33
3.67
3.93
1.2
1.2
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
12
33
3.67
3.93
1.8
2.6
u/ml
954.2
697.7
0.42
12
33
(3051611) Lipemic interference index of Serum or Plasma
20
76
2.67
3.92
2.0
3.3
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
13
38
3.46
3.91
1.2
1.6
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
19
71
2.71
3.84
5.5
2.8
%
54.2
58.9
0.29
12
47
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
756
7054
1.41
3.82
30.7
13.1
ml/min/173m2
77.8
79.3
0.95
693
5776
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
15
49
3.10
3.82
1.1
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
15
49
3.10
3.82
1.1
1.2
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
11
29
3.83
3.81
2.0
2.7
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
76
481
1.63
3.79
8.8
7.7
mmol/l
24.4
24.4
0.02
71
447
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
25
108
2.35
3.78
1.1
1.1
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
21
84
2.54
3.73
1.4
1.5
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
36
182
2.02
3.73
1.8
1.7
e6/l
11008.1
16756.2
0.57
27
132
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
10
25
4.03
3.70
1.2
1.1
ug/l
10.8
9.0
—
10
25
(3044941) Cell count panel - Synovial fluid
27
122
2.25
3.70
1.4
1.5
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
8
12
6.71
3.68
1.4
1.4
—
—
—
0
0
(3022313) Gas panel - Capillary blood
62
375
1.70
3.67
5.8
3.7
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
94
635
1.54
3.57
2.6
2.5
ug/l
5.1
7.2
1.17
77
553
(3012441) Differential panel - Pleural fluid
20
80
2.53
3.56
1.5
1.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
42
228
1.88
3.56
1.5
1.6
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
42
228
1.88
3.56
4.1
3.7
mmol/l
3.9
3.9
0.11
35
209
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
7
9
7.83
3.56
1.3
1.3
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
10
26
3.88
3.53
1.0
1.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
61
375
1.67
3.42
2.4
2.4
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
21
88
2.42
3.41
1.0
1.1
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
24
107
2.28
3.41
1.4
1.5
g/l
34.8
31.7
0.38
17
93
(3019550) Sodium [Moles/volume] in Serum or Plasma
815
7746
1.48
3.39
35.4
16.5
mmol/l
139.1
139.6
7.14
800
7544
(3027456) Digoxin [Moles/volume] in Serum or Plasma
35
183
1.95
3.33
3.8
3.3
nmol/l
0.8
0.9
0.20
25
144
(3024928) Oxygen saturation in Venous blood
33
169
1.99
3.32
3.1
3.7
—
—
—
0
0
(3016330) Potassium [Moles/time] in 24 hour Urine
6
7
8.62
3.26
1.0
1.3
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
16
60
2.70
3.24
2.8
1.3
%
22.6
27.5
—
7
39
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
52
312
1.71
3.20
2.8
1.8
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
831
7948
1.50
3.14
20.3
10.2
u/l
26.2
25.8
0.37
810
7650
(3023103) Potassium [Moles/volume] in Serum or Plasma
815
7767
1.46
3.12
35.8
16.7
mmol/l
4.0
4.0
0.28
797
7552
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
9
20
4.53
3.12
1.0
1.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
497
4438
1.26
3.05
3.1
2.9
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
31
161
1.96
3.02
1.3
1.4
u/l
13.5
9.3
0.82
23
126
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
33
176
1.91
2.99
1.2
1.1
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
5
5
10.04
2.98
2.0
1.0
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
17
69
2.49
2.97
1.1
1.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
23
108
2.16
2.92
3.2
2.6
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
16
64
2.53
2.88
2.2
2.4
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
48
291
1.69
2.87
2.6
1.6
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
7
13
5.42
2.87
1.1
1.3
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
6
9
6.70
2.87
1.3
1.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
12
41
2.95
2.86
1.0
1.0
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
15
59
2.57
2.79
1.1
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
10
31
3.25
2.78
1.1
1.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
19
393
0.47
2.78
1.3
1.4
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
5
6
8.37
2.75
1.2
1.2
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
113
836
1.40
2.73
2.0
1.8
%
1.8
1.5
2.56
95
736
(44813793)
14
54
2.62
2.71
1.1
1.1
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
8
19
4.24
2.68
1.9
2.9
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
10
32
3.15
2.65
1.1
1.1
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
20
93
2.18
2.62
1.4
1.4
e6/l
1670.3
1575.8
0.04
12
64
(3024471) HLA-A [Type]
7
15
4.69
2.60
1.0
1.0
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
7
15
4.69
2.60
1.0
1.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
61
404
1.55
2.58
1.5
1.2
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
25
128
1.98
2.57
1.1
1.5
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
8
20
4.03
2.57
1.0
1.0
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
16
68
2.38
2.56
1.1
1.2
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
5
7
7.18
2.55
1.0
1.4
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
15
62
2.44
2.55
1.1
1.8
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
10
33
3.05
2.53
1.1
1.3
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
30
165
1.85
2.51
1.6
1.3
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
18
82
2.22
2.48
1.4
1.3
e6/l
11472.3
47702.4
—
8
47
(3010144) Erythrocytes [#/volume] in Synovial fluid
15
63
2.40
2.47
1.7
1.4
e6/l
8236.3
73624.7
—
8
43
(3045414) Leukocytes [Presence] in Urine
51
330
1.58
2.40
2.5
1.8
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
8
22
3.66
2.36
2.4
2.1
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
8
22
3.66
2.36
1.0
1.0
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
13
52
2.52
2.36
1.0
1.1
—
—
—
0
0
(3017704) Immunofixation for Urine
12
46
2.63
2.36
1.1
1.6
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
19
91
2.11
2.34
4.7
3.6
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
16
72
2.24
2.28
1.7
1.3
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
37
225
1.67
2.24
1.4
1.5
ug/g
277.7
299.0
0.27
23
137
(3013139) Helicobacter pylori Ag [Presence] in Stool
64
444
1.47
2.22
1.3
1.2
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
5
9
5.58
2.21
11.6
10.2
mmol/l
4.2
7.1
—
5
9
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
60
413
1.48
2.16
9.8
10.4
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
16
74
2.18
2.15
1.0
1.3
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
6
14
4.31
2.15
4.3
5.7
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
32
190
1.71
2.12
1.4
1.3
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
12
49
2.47
2.11
2.0
3.4
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
31
184
1.71
2.06
1.3
1.3
miu/ml
197.6
224.7
—
8
85
(3024932) HLA-DR beta [Type]
6
15
4.02
2.04
1.2
1.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
16
76
2.12
2.03
1.1
1.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
13
57
2.30
1.98
1.2
1.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
38
580
0.64
1.97
1.5
1.8
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
7
21
3.35
1.96
1.1
1.0
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
7
21
3.35
1.96
1.0
1.0
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
6
16
3.77
1.93
1.2
1.4
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
29
173
1.70
1.91
1.6
2.0
u/l
3104.5
3383.6
—
8
68
(3013727) Leukocytes other/100 leukocytes in Blood
8
28
2.87
1.86
3.1
5.5
%
48.7
51.3
—
8
28
(21494755) Public health laboratory ask at order entry panel
42
616
0.67
1.82
1.3
1.4
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
68
500
1.39
1.77
1.7
1.6
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
6
18
3.35
1.75
3.3
1.6
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
194
1646
1.23
1.73
6.7
3.9
kg/l
1.0
1.0
0.54
26
237
(4015189)
7
24
2.93
1.72
1.3
2.4
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
5
130
0.38
1.63
1.0
1.4
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
24
143
1.70
1.62
1.1
1.5
e6/l
5.3
164.3
1.79
15
117
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
24
143
1.70
1.62
1.1
1.4
e6/l
7.4
31.3
0.52
14
112
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
5
14
3.58
1.61
2.0
1.8
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
10
43
2.34
1.60
1.2
2.0
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
10
43
2.34
1.60
1.3
1.2
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
13
63
2.08
1.60
1.6
1.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
13
63
2.08
1.60
1.6
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
13
63
2.08
1.60
1.6
1.5
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
6
20
3.01
1.58
2.8
1.9
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
7
26
2.70
1.58
1.3
1.9
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
7
26
2.70
1.58
1.0
1.0
miu/ml
1302.3
1523.0
—
7
26
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
18
99
1.83
1.58
1.4
1.2
nmol/l
0.5
0.6
1.38
18
94
(3003338) MCHC [Mass/volume]
590
6234
0.85
1.58
40.0
18.6
g/l
328.4
332.1
15.30
585
6181
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
17
92
1.86
1.56
1.1
1.0
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
17
92
1.86
1.56
1.2
1.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
705
6739
1.20
1.55
29.2
15.7
%
38.4
39.7
2.58
452
4737
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
12
57
2.12
1.55
2.3
1.1
—
—
—
0
0
(3011648) Oxygen content in Venous blood
12
57
2.12
1.55
1.8
4.7
%
13.8
11.0
1.23
12
57
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
13
64
2.05
1.54
1.5
1.3
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
5
15
3.35
1.52
1.0
1.0
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
11
51
2.17
1.51
5.8
2.5
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
6
21
2.87
1.50
1.2
1.3
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
10
45
2.24
1.46
2.3
3.1
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
10
45
2.24
1.46
1.6
1.2
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
10
45
2.24
1.46
1.6
1.2
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
9
38
2.38
1.46
1.2
1.7
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
6
136
0.44
1.41
1.5
1.6
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
34
230
1.50
1.41
2.2
1.6
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
34
231
1.49
1.38
2.2
1.6
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
41
290
1.43
1.37
2.1
2.8
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
801
7778
1.24
1.36
28.0
13.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
34
232
1.48
1.36
2.2
1.6
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
39
0.00
1.34
0.0
6.4
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
18
105
1.73
1.34
1.1
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
11
54
2.05
1.33
1.0
1.1
—
—
—
0
0
(44790047)
15
83
1.82
1.32
1.3
1.5
—
—
—
0
0
(44806118)
15
83
1.82
1.32
1.3
1.5
—
—
—
0
0
(44790049)
15
83
1.82
1.32
1.3
1.5
—
—
—
0
0
(44790048)
15
83
1.82
1.32
1.3
1.5
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
8
34
2.36
1.29
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
8
34
2.36
1.29
1.0
1.0
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
10
48
2.10
1.28
1.0
1.3
—
—
—
0
0
(3036603) Volume of Urine
11
55
2.01
1.27
1.5
1.5
—
1933.2
—
0
13
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
16
92
1.75
1.25
1.5
1.2
nmol/l
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
59
452
1.33
1.24
1.2
1.2
iu/ml
131.1
130.6
0.00
27
184
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
6
25
2.41
1.24
3.7
3.3
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
6
25
2.41
1.24
3.7
3.3
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
8
36
2.23
1.24
1.0
1.1
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
10
49
2.05
1.22
1.6
1.5
—
—
—
0
0
(3000492) Spirometry study
87
706
1.26
1.20
1.7
1.5
—
—
—
0
0
(4198724)
6
26
2.32
1.19
3.0
1.8
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
8
38
2.11
1.18
1.5
1.2
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
8
38
2.11
1.18
2.3
3.4
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
52
674
0.76
1.15
2.8
2.0
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
8
39
2.06
1.15
1.9
1.5
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
8
39
2.06
1.15
1.9
1.5
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
8
39
2.06
1.15
1.9
1.5
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
8
39
2.06
1.15
1.9
1.5
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
33
234
1.43
1.12
1.3
1.1
—
—
—
0
0
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
7
31
2.27
1.10
1.6
1.3
nmol/l
73.7
106.1
—
7
23
(3016879) Cocaine [Presence] in Urine
31
218
1.44
1.10
2.3
1.6
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
727
7031
1.17
1.10
4.2
3.9
mmol/l
1.4
1.3
3.39
656
6366
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
5
21
2.39
1.09
1.6
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
5
21
2.39
1.09
1.6
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
5
21
2.39
1.09
1.6
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
5
21
2.39
1.09
1.6
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
33
236
1.41
1.08
1.3
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
22
145
1.53
1.06
1.5
1.3
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
79
961
0.81
1.06
5.3
4.5
%
32.6
32.3
0.13
55
633
(3011288) Drugs identified in Urine by Screen method
23
154
1.51
1.04
3.8
2.0
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
32
230
1.41
1.03
2.3
1.6
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
845
8292
1.25
1.02
46.3
20.9
e9/l
254.6
248.1
1.60
831
8066
(3024731) MCV [Entitic volume]
845
8293
1.25
1.01
46.2
20.8
fl
92.0
91.1
4.90
836
8157
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
54
423
1.29
1.01
2.3
3.1
pmol/l
4.0
4.5
3.10
47
377
(3035941) MCH [Entitic mass]
845
8294
1.25
1.00
46.1
20.8
pg
30.2
30.3
0.56
836
8156
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
7
35
2.01
1.00
1.7
1.1
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
7
35
2.01
1.00
1.7
1.1
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
845
8295
1.25
1.00
46.3
20.9
e12/l
4.3
4.5
14.93
830
8044
(3010813) Leukocytes [#/volume] in Blood
845
8296
1.25
0.99
46.4
20.9
e9/l
7.6
6.7
14.09
831
8041
(3016018) Differential panel - Cerebral spinal fluid
11
61
1.81
0.98
1.1
1.7
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
29
0.00
0.98
0.0
1.3
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
7
36
1.95
0.97
8.9
3.5
u/l
200.3
212.0
—
7
36
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
34
250
1.37
0.97
1.5
1.6
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
845
8299
1.24
0.96
46.7
21.0
g/l
129.3
134.9
21.61
835
8158
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
11
62
1.78
0.94
1.0
1.0
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
748
7275
1.16
0.93
5.2
4.6
mmol/l
6.0
6.0
0.38
682
6573
(1761482) Bacteria [#/volume] in Urine by Culture
29
209
1.40
0.93
3.9
4.8
—
—
—
0
0
(3035880) pH of Pleural fluid
10
55
1.83
0.92
1.6
1.4
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
26
185
1.42
0.90
2.2
1.5
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
6
29
2.08
0.89
2.2
1.6
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
6
29
2.08
0.89
2.2
1.6
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
768
7492
1.16
0.88
5.1
4.9
mmol/l
2.5
2.7
9.31
688
6853
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
6
30
2.01
0.87
2.2
1.5
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
13
80
1.63
0.85
1.6
1.6
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
15
96
1.57
0.84
2.0
1.3
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
96
823
1.19
0.82
3.8
4.2
ug/l
86.3
28.9
0.51
75
679
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
11
65
1.70
0.82
1.1
1.3
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
753
7345
1.14
0.82
4.7
4.4
mmol/l
4.4
4.6
9.89
678
6751
(3019225) pH of Specimen
89
759
1.19
0.81
5.9
3.9
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
49
607
0.80
0.81
2.7
1.9
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
16
106
1.52
0.79
1.1
1.2
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
15
98
1.54
0.78
2.1
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
15
98
1.54
0.78
2.1
1.2
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
6
34
1.77
0.76
1.0
1.3
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
10
59
1.70
0.76
1.5
1.9
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
12
75
1.61
0.75
1.7
1.6
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
17
116
1.47
0.74
1.2
1.1
u/ml
0.6
3.5
—
10
49
(3028707) Methadone [Presence] in Urine by Screen method
16
108
1.49
0.74
2.1
1.8
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
747
7296
1.13
0.74
4.6
4.4
mmol/l
1.4
1.5
5.72
673
6658
(3023323) Follitropin [Units/volume] in Serum or Plasma
33
255
1.31
0.72
1.6
1.3
iu/l
18.7
28.3
1.25
27
215
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
7
41
1.71
0.70
1.1
1.5
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
7
41
1.71
0.70
1.1
1.5
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
17
239
0.71
0.69
1.1
1.7
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
30
231
1.31
0.68
1.3
1.1
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
9
59
1.53
0.68
1.3
1.1
nmol/l
1.3
1.5
—
9
50
(3038177) Helicobacter pylori Ab [Presence] in Serum
15
102
1.48
0.67
1.0
1.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
273
2549
1.10
0.66
2.9
2.8
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
17
120
1.42
0.65
1.5
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
14
96
1.47
0.61
2.1
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
14
96
1.47
0.61
2.1
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
14
97
1.45
0.59
2.1
1.3
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
8
53
1.51
0.58
1.5
1.8
nmol/l
17.3
21.7
—
8
48
(3004716) Salmonella sp identified in Stool by Organism specific culture
45
375
1.21
0.56
1.3
1.3
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
15
107
1.41
0.55
1.2
1.1
u/ml
10.9
4.3
—
5
56
(1617658) Protocol used for examination of sentinel lymph nodes
9
60
1.50
0.54
1.0
1.1
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
14
99
1.42
0.54
1.3
1.1
u/ml
—
5.0
—
0
21
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
13
91
1.43
0.53
3.7
3.6
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
6
39
1.54
0.53
1.0
1.2
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
15
203
0.73
0.52
1.5
1.6
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
9
65
1.39
0.50
1.2
1.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
58
502
1.17
0.50
2.4
3.1
e9/l
5.2
4.0
2.34
42
382
(3035320) C reactive protein [Mass/volume] in Body fluid
7
47
1.49
0.47
3.7
2.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
26
321
0.80
0.47
1.8
1.9
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
69
780
0.88
0.47
1.5
1.6
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
10
68
1.48
0.47
1.1
1.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
15
111
1.36
0.47
5.4
2.8
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
14
103
1.36
0.45
1.1
1.1
u/ml
0.2
1.1
—
5
42
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
10
69
1.45
0.44
2.7
2.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
14
104
1.35
0.43
1.0
1.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
23
185
1.25
0.42
1.0
1.2
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
8
58
1.38
0.41
2.8
2.1
ug/l
2.5
2.2
—
8
46
(3045683) HLA typing for celiac disease panel - Blood or Tissue
5
33
1.52
0.41
1.0
1.0
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
5
33
1.52
0.41
2.8
2.4
—
—
—
0
0
(4133840)
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
14
105
1.34
0.41
1.0
1.1
—
—
—
0
0
(3024263) Appearance of Synovial fluid
5
36
1.39
0.38
1.8
1.5
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
5
36
1.39
0.38
1.8
1.1
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
5
37
1.35
0.37
1.0
13.3
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
5
76
0.66
0.36
1.0
1.6
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
9
125
0.72
0.35
2.3
1.7
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
42
368
1.15
0.34
3.5
3.1
u/ml
47.9
59.1
0.22
42
353
(4094501)
22
182
1.21
0.33
1.0
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
55
496
1.12
0.30
3.7
3.1
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
10
75
1.34
0.30
1.3
1.1
u/ml
—
6.4
—
0
26
(36660697) Celiac disease serology panel - Serum
60
547
1.10
0.28
1.2
1.2
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
8
63
1.27
0.28
2.0
2.2
umol/l
19.6
8.2
—
8
44
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
19
159
1.20
0.27
1.1
1.4
nmol/l
1.2
0.9
0.46
12
133
(3000330) Specific gravity of Urine by Test strip
44
395
1.12
0.27
4.1
3.8
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
8
67
1.20
0.26
1.5
1.3
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
57
524
1.09
0.23
2.9
2.2
nmol/l
12.7
13.4
0.20
45
461
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
16
190
0.84
0.23
2.1
1.8
nmol/l
34.6
39.0
0.46
16
179
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
12
0.00
0.21
0.0
6.8
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
8
103
0.77
0.21
1.5
1.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
201
1940
1.05
0.21
1.5
1.4
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
99
937
1.06
0.21
12.7
6.8
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
10
80
1.25
0.20
1.7
1.7
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
237
2310
1.04
0.16
4.6
4.9
ug/l
2.3
2.9
0.56
212
2061
(4146454)
10
83
1.21
0.15
3.4
2.7
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
196
2010
0.97
0.13
1.7
1.6
mmol/l
1.4
1.4
0.51
153
1696
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
5
47
1.06
0.09
1.0
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
19
174
1.09
0.09
3.4
2.2
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
6
55
1.09
0.09
1.7
1.4
—
—
—
0
0
(4010399)
57
548
1.04
0.08
1.6
1.5
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
21
195
1.08
0.08
1.4
1.4
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
7
68
1.03
0.08
1.1
1.5
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
8
92
0.87
0.06
2.4
2.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
24
254
0.94
0.06
1.8
1.8
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
104
1019
1.02
0.06
1.5
1.4
—
—
—
0
0
(1002224) Polysomnography panel
30
287
1.05
0.05
1.1
1.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
133
1341
0.99
0.02
2.6
2.9
ug/l
0.6
0.8
1.25
94
863
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
34
347
0.98
0.01
1.1
1.0
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
21
204
1.03
0.00
1.2
1.4
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
32
326
0.98
0.00
1.7
1.6
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
61
616
0.99
0.00
1.4
1.4
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
185
1846
1.00
0.00
3.9
4.2
%
21.3
21.2
0.00
83
873
(40768800) Prostate Pathology biopsy report
14
143
0.98
0.00
1.5
1.2
—
—
—
0
0
(4034850)
25
251
1.00
0.00
12.2
10.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
19
189
1.01
0.00
1.1
1.3
—
—
—
0
0
(3008898) HLA-B27 [Presence]
25
253
0.99
0.00
1.1
1.1
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
7
0.00
0.00
0.0
3.4
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
13.6
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
9
94
0.96
0.00
1.6
1.6
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3010015) Selenium [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
1.4
—
0
5
(3051339) Copper [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.2
—
16.7
—
0
5
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044416) Complement C4 [Mass/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
0.0
—
0
5
(40758358) Immune stain study
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(4281824)
9
89
1.01
0.00
1.0
1.1
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: L12_VASCULITISSKIN – Vasculitis limited to skin, not elsewhere classified

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).